Showing results (21-30 of 288) with videos related to
Sort By:
Pageof 29
Neuroepidemiology|January 1, 1985
Methodological aspects of drug trials in migraineP Tfelt-Hansen, J OlesenCephalalgia : an International Journal of Headache|March 1, 1981
Ergotamine abuse. Do patients benefit from withdrawal?P Tfelt-Hansen, A KrabbeActa Pharmacologica Et Toxicologica|September 1, 1984
Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in manP Tfelt-Hansen, P M MannichePharmacology & Toxicology|September 1, 1993
No effect of the 5HT2-antagonist ICI 169,369 on systolic, ergotamine-induced blood pressure changes in manT H Nielsen, P Tfelt-HansenClinical Physiology (Oxford, England)|February 1, 1982
Local regulation of subcutaneous blood flow in normal subjects and in migraine patients before and after single-dose ergotamine tartrateJ H Eickhoff, P Tfelt-HansenNeurology|November 23, 2000
Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trialsP Tfelt-Hansen, R E RyanCephalalgia : an International Journal of Headache|January 1, 1989
Lack of effect of GR43175 on peripheral arteries in manT H Nielsen, P Tfelt-HansenCephalalgia : an International Journal of Headache|March 3, 2009
Finding new drug targets for the treatment of migraine attacksJ Olesen, P Tfelt-Hansen, M AshinaEuropean Journal of Clinical Pharmacology|January 1, 1991
Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disordersI Jansen, P Tfelt-Hansen, L EdvinssonCephalalgia : an International Journal of Headache|October 18, 2002
Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trialsP Tfelt-Hansen, K McCarroll, C LinesPageof 29